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A common characteristic of irritable bowel syndrome (IBS) is that symptoms, including abdominal 
pain and abnormal bowel habits, are often triggered or exacerbated during periods of stress 
and anxiety. However, the impact of anxiety and affective disorders on the gastrointestinal (GI) 
tract is poorly understood and may in part explain the lack of effective therapeutic approaches 
to treat IBS. The amygdala is an important structure for regulating anxiety with the central 
nucleus of the amygdala facilitating the activation of the hypothalamic-pituitary-adrenal axis 
and the autonomic nervous system in response to stress. Moreover, chronic stress enhances 
function of the amygdala and promotes neural plasticity throughout the amygdaloid complex. 
This review outlines the latest findings obtained from human studies and animal models related 
to the role of the emotional brain in the regulation of enteric function, specifically how increasing 
the gain of the amygdala to induce anxiety-like behavior using corticosterone or chronic stress 
increases responsiveness to both visceral and somatic stimuli in rodents. A focus of the review 
is the relative importance of mineralocorticoid receptor and glucocorticoid receptor-mediated 
mechanisms within the amygdala in the regulation of anxiety and nociceptive behaviors that 
are characteristic features of IBS. This review also discusses several outstanding questions 
important for future research on the role of the amygdala in the generation of abnormal GI 
function that may lead to potential targets for new therapies to treat functional bowel disorders 
such as IBS.
Keywords: irritable bowel syndrome, visceral hypersensitivity, anxiety, amygdala, corticosterone, hypothalamic-pituitary-
adrenal axis
connectivity of the amygdala uniquely positions the complex to 
modulate the function of theses cortical structures and serve as an 
integrator of emotional and enteric physiology (Bonaz et al., 2002; 
McDonald et al., 1996; Naliboff et al., 2006; Shi and Cassell, 1998; 
Wilder-Smith et al., 2004). As we discuss the role of the amygdala 
in the regulation of visceral pain, we will also provide evidence 
for a convergence of visceral and somatic sensation because of 
the significant proportion of IBS patients with co-morbid somatic 
disorders such as fibromyalgia (Chang et al., 2000; Riedl et al., 2008; 
Verne et al., 2001). Recent advances in our understanding of altered 
central nervous system (CNS) activity in IBS patients have emerged 
from human brain imaging and we will briefly outline the major 
findings from these studies along with results from small animal 
imaging to support the hypothesis of amygdala hyperactivity in IBS 
patients. An additional characteristic of IBS is the marked female 
predominance of the disorder and we will summarize the sex dif-
ferences in central processing of visceral stimuli and the lessons 
learned from animal models on the role of ovarian hormones in 
the regulation of anxious behavior, visceral sensitivity, and somatic 
pain. A significant portion of this review will be dedicated to the 
effects of amygdala manipulation on anxiety, visceral sensation, and 
somatic thresholds with specific sections devoted to the actions of 
stress hormones such as corticosteroids (CORT) and corticotropin 
releasing factor (CRF). We also address other important messengers 
IntroductIon
Irritable bowel syndrome (IBS) is a common gastrointestinal (GI) 
disorder characterized by abnormal bowel patterns and abdominal 
pain that affects 10–15% of North Americans (Talley et al., 1992). 
A prominent feature of IBS symptomatology is altered visceral 
perception exhibited by hypersensitivity of the colon to luminal 
distension (Ritchie, 1973; Whitehead et al., 1980). Although the 
direct cost of IBS is approximately $1.7 billion annually, the etiology 
of the illness is still unknown and no FDA-approved therapies are 
available to patients (Hulisz, 2004). In this review we discuss the 
relationship between IBS and anxiety with a special emphasis on the 
importance of the amygdala as a site integrating emotional behavior 
and visceral pain processing. Although other brain sites including 
the cingulate, prefrontal, and insular cortices have been implicated 
in the regulation of both affective and visceral   functions, the vast 
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Our group has demonstrated that, in rodents, there is a link 
between the central pathways mediating stress and anxiety and the 
mechanisms regulating GI sensitivity (Greenwood-Van Meerveld 
et al., 2001). A key component of this link is the amygdala, specifi-
cally the central nucleus of the amygdala (CeA). The role of the 
amygdala in the regulation of emotional behavior is well established; 
however, recent work has shown that this limbic structure integrates 
emotional and sensory information and is a vital site for the expres-
sion of fear and anxiety (Davis, 1992, 1997; Phelps and LeDoux, 
2005; Schulkin et al., 1994; Weiskrantz, 1956). Additionally, the 
amygdala is involved in the learning, consolidation, and acquisition 
of emotional memories and has an essential role in classically con-
ditioned responses (Davis, 1997; LeDoux, 2000). These functions 
are closely related to the role of the amygdala in the generation 
of fear and may be important for IBS as studies in rodents have 
demonstrated that colonic sensitivity and motility are increased fol-
lowing fear conditioning (Gue et al., 1991; Tyler et al., 2007). There 
are approximately 13 nuclei of the amygdala that are anatomi-
cally and physiologically heterogeneous but these structures can 
be grouped into three complexes based on functional interactions 
(Sah et al., 2003). These are the frontotemporal (basal, lateral, and 
accessory basal nuclei), autonomic (central and medial nuclei), and 
olfactory groups (main and accessory olfactory systems) (Swanson, 
2000; Swanson and Petrovich, 1998). The CeA facilitates both the 
autonomic and endocrine responses to stress and stimulation 
of the CeA produces activity consistent with heightened anxiety 
such as enhanced startle, freezing behavior, and increased plasma 
CORT (Applegate et al., 1983; Dunn and Whitener, 1986; Rosen and 
Davis, 1988). Conversely, lesions of the CeA decrease anxiety-like 
behaviors associated with conditioned fear, novel environments, 
and social stress (Burns et al., 1996; Roozendaal et al., 1990). CeA 
lesions also reduce baseline CRF expression in the hypothalamus 
and stress-induced release of ACTH and CORT (Beaulieu et al., 
1986; Prewitt and Herman, 1994). Anatomical studies indicate that 
the CeA provides major output to autonomic regions that mediate 
not only fear and anxiety-related behaviors but also enteric proc-
esses such as gastric emptying and colonic motility (LeDoux et al., 
1988; Lyubashina, 2004; Swanson and Petrovich, 1998). A summary 
of the anatomical connectivity of the amygdala with projections 
relevant to the integration of visceral and somatic pain, motor 
activity of the GI tract, as well as stress and anxiety is displayed in 
Figure 1. Although the role of the amygdala in the regulation of GI 
motor function is an understudied area, electrical stimulation of 
the CeA can inhibit gastric motility through direct projections from 
the CeA to the dorsal motor nucleus of the vagus and nucleus of the 
solitary tract (Krettek and Price, 1978; Lyubashina, 2004; Schwaber 
et al., 1982). In addition, Figure 2 illustrates the projections from 
the CeA to the locus coeruleus (LC) and Barrington’s nucleus that 
modify distal colonic motility through manipulation of the sacral 
parasympathetic nucleus (Sakanaka et al., 1986; Valentino et al., 
1999). The network of projections from the CeA to the periaq-
ueductal gray (PAG), LC, raphe nuclei, and parabrachial nucleus 
participates in ascending arousal and affective systems as well as the 
descending modulation of nociceptive afferents and represents a 
mechanism for altered visceral and somatic sensation (Davis, 1997; 
Jones et al., 2006; Sah et al., 2003). Given that episodes of anxiety 
and stress are linked to the symptomatology of IBS, we hypothesize 
regulating amygdala function including protein kinase A (PKA), 
extracellular signal-regulated kinase (ERK), calcium-calmodulin-
dependent protein kinase II (CaMKII) and neurotropic factors 
that may represent targets for novel therapeutic approaches to the 
treatment of IBS.
AnxIety And IBS: whAt IS the connectIon?
IBS patients report more frequent stressors and greater impact 
of stressful events on daily life than controls; additionally, IBS 
symptomatology is often exacerbated during periods of stress 
and there is a statistically significant relationship between stress, 
bowel symptoms, illness-related absenteeism, and medical clinic 
visits (Blanchard et al., 2008; Whitehead et al., 1990, 1992). Levels 
of chronic life stress can also predict clinical outcome in IBS 
patients which can be demonstrated by the temporal relationship 
between life stress and the subsequent intensity of bowel symp-
toms (Bennett et al., 1998). Furthermore, a statistical correlation 
among mean daily stress, indices of anxiety and depression, and 
GI symptoms including abdominal pain, bloating, and altered 
bowel patterns suggests that altered activity in stress-regulating 
pathways may be an important component of IBS symptomatol-
ogy (Hertig et al., 2007). Recent clinical studies have implicated 
hypothalamic-pituitary-adrenal (HPA) axis dysregulation in the 
pathophysiology of IBS by demonstrating that patients possess 
elevated cortisol levels both at baseline and in response to stress 
(Chang et al., 2009; Dinan et al., 2006). Additionally, the CRF 
stimulation test has been used to demonstrate exaggerated adren-
ocorticotropic hormone (ACTH), cortisol, and colonic motility 
responses in IBS patients compared to healthy controls (Dinan 
et al., 2006; Fukudo et al., 1998). This stress hyper-responsiveness 
may be responsible for the increased level of psychopathology 
in IBS patients compared to patients with other GI disorders 
such as inflammatory bowel disease (Blanchard et al., 1990). The 
diagnosis rate of psychiatric disorders in treatment-seeking IBS 
patients ranges from 54 to 94% and anxiety disorders are the 
most common psychiatric co-morbidities with up to 61% of 
treatment-seeking IBS patients possessing a DSM-IV-diagnosed 
anxiety disorder (Drossman et al., 1999; Whitehead et al., 2002). 
Clinical studies consistently report an association between anxi-
ety and IBS with panic, generalized anxiety, and post-traumatic 
stress representing the most prevalent anxiety disorders in IBS 
patients (Blanchard et al., 1990; Jones et al., 2006; Lydiard, 2001). 
Although there is an argument that these findings may be a result 
of selection bias because these studies only examine treatment-
seeking patients who may be more prone to medical complaints 
in general, a community-based survey found not only that rates 
of clinically diagnosed anxiety disorders were significantly higher 
in IBS patients than the general population but also that the 
rates for nontreatment-seeking patients were similar to treat-
ment-seekers (Lydiard and Falsetti, 1999). IBS patients also show 
increased fear-potentiated acoustic startle responses compared 
with controls, suggesting central hyper-excitability and increased 
vigilance (Naliboff et al., 2008). Although these findings do not 
eliminate the possibility that treatment-seekers possess atypical 
illness-related attitudes and/or hypochondriacal personalities, 
they offer strong support for the hypothesis that anxiety and 
IBS share common biological factors.
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Figure 1 | Mechanisms for amygdala-mediated integration of abdominal 
and cutaneous pain, gi motility, and anxiety. All projections are reciprocal 
and connectivity is simplified for clarity. Ach, acetylcholine; AVP , arginine 
vasopressin; BN, Barrington’s nucleus; BNST, bed nucleus of the stria terminalis; 
CCK, cholecystokinin; CGRP , calcitonin gene-related peptide; CRF , corticotropin 
releasing factor; DMV, dorsal motor nucleus of the vagus; Glu, glutamate; Hypo, 
hypothalamus; LC, locus coeruleus; NE, norepinephrine; NO, nitric oxide; NTS, 
nucleus of the solitary tract; PAG, periaqueductal gray; PBN, parabrachial 
nucleus; RN, raphe nuclei; SP , substance P; VIP , vasoactive intestinal peptide; 
5-HT, serotonin (Choi et al., 2007; Davis, 1997; Gray and Magnuson, 1987; 
Hermanson et al., 1998; Jones et al., 2006; Niedringhaus et al., 2008; Sah et al., 
2003; Sakanaka et al., 1986).
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Figure 2 | Hypothesized pathways representing the primary amygdala-
peripheral interactions. Sensory-motor interactions between the amygdala 
and proximal colon are mediated by the vagus nerve and the nuclei of the 
dorsal vagal complex. The amygdala also influences distal colonic motility 
through the pelvic nerve via the LC/BN complex while convergence of 
visceral and somatic afferents occurs in the lumbosacral spinal cord. Red 
represents afferent pathways and green depicts efferent connections. BLA, 
basolateral nucleus of the amygdala; BN, Barrington’s nucleus; CeA, central 
nucleus of the amygdala; DMV, dorsal motor nucleus of the vagus; ENS, 
enteric nervous system; HPA, hypothalamic-pituitary-adrenal; LC, locus 
coeruleus; MeA, medial nucleus of the amygdala; NTS, nucleus of the 
solitary tract.
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that a connection exists between the amygdala and enteric responses 
to behavioral situations.
ImAgIng the neurAl cIrcuItry of AmygdAlA 
hyperActIvIty
In recent years, imaging studies using both functional magnetic 
resonance imaging (fMRI) and positron emission tomography 
(PET) have demonstrated that, compared to healthy controls, IBS 
patients display altered central processing of visceral sensory infor-
mation. In healthy subjects, visceral stimulation consistently acti-
vates the insular cortex, an important area for perception of internal 
body states, and the anterior portion of the cingulate cortex, a 
region that mediates affective-sensory and motivational processes 
(Derbyshire, 2003). These studies have also demonstrated activa-
tion in other areas including the primary sensory and prefrontal 
cortices (Derbyshire, 2003). IBS patients show activation of many 
of the same structures but also show substantial activation of the 
hypothalamus and amygdala as well as decreased activity of the anti-
nociceptive PAG (Naliboff et al., 2001). More recent investigations 
employing rectosigmoid balloon distension in IBS patients have 
shown activity in a network of brain structures involved in both 
sensory-discriminative functions as well as emotional-motivational 
processes. Specifically, areas regulating affective and sensory proc-
esses including the amygdala, insula, cingulate, and prefrontal cor-
tex show greater activation in IBS patients than controls (Naliboff 
et al., 2003; Wilder-Smith et al., 2004). Additionally, neuroimaging 
studies in subjects with mood disorders have shown that resting 
cerebral blood flow (CBF) and glucose metabolism are abnormally 
elevated in the amygdala and elevations in amygdala CBF persist for 
an abnormally long time in response to a stressor (Drevets, 2003). 
Although fMRI is a powerful tool for noninvasive imaging of brain 
function, very little research has used the technique to examine 
central processing in animal models of visceral hypersensitivity. 
However, in a study performed in anesthetized adult rats, fMRI was 
used to detect brain areas activated by colorectal distension (CRD) 
(Lazovic et al., 2005). Additionally, fMRI activation was compared 
with postmortem histological analysis of the immediate early gene 
product c-fos to establish whether fMRI results are comparable 
to c-fos expression. The CeA displayed a significant number of 
c-fos positive cells in response to visceral stimulation and all rats 
undergoing fMRI exhibited activation of the amygdaloid complex 
in response to CRD. This study also demonstrated that, although 
c-fos had greater resolution for identifying neuronal activation in 
specific subnuclei, fMRI was a more sensitive and selective method 
for comparing animals undergoing CRD with controls. In recent 
work, these observations have been advanced by showing that, in 
anesthetized rats, there are significant differences in brain activa-
tion in response to CRD following modulation of amygdala func-
tion (Johnson et al., 2007). This was accomplished by investigating 
whole brain fMRI in anesthetized rats to identify brain regions acti-
vated by visceral stimulation following exposure of the amygdala 
to high levels of CORT. These experiments provided evidence that 
elevated amygdaloid CORT significantly increases brain activation 
in response to visceral stimulation compared to controls, suggesting 
a stress-induced afferent neuronal hypersensitivity. The informa-
tion obtained in this study provided pivotal data supporting the 
hypothesis that the amygdala is important for the sensitization of 
a neuronal sensory circuit and these results complement studies 
in conscious rats in which CORT was stereotaxically administered 
onto the amygdala and found to induce anxiety and a heightened 
visceromotor behavioral response to CRD (Myers and Greenwood-
Van Meerveld, 2007). However, one limitation of data from these 
animal imaging studies is that the animals must be anesthetized 
while, in clinical studies, IBS patients are awake. To address this 
issue, others have utilized CRD in awake, nonrestrained rodents 
injected with a radioactive tracer for quantifying regional CBF 
(Wang et al., 2008). Although the autoradiographic reconstruc-
tion of CBF occurred postmortem, the analysis yielded interesting 
results including increases in CBF in the amygdala, insula, and 
anterior cingulate cortex. Overall, brain imaging studies from both 
humans and rodents suggest that hyperactivity of the amygdala 
plays an important role in the altered central processing of visceral 
information seen in IBS patients.
the role of gender
Irritable bowel syndrome is one of the most common disorders 
outside of gynecological diseases that influence women’s work 
productivity due to frequent and potentially disabling symptoms. 
Studies have demonstrated that approximately two-thirds of indi-
viduals with IBS are female, with an estimated prevalence in women 
ranging from 14–24% (Drossman et al., 1997). Similarly, anxiety 
disorders are twice as prevalent in females compared to males 
providing further evidence for common biological factors in the 
pathophysiology of these disorders (Seeman, 1997). A potential 
explanation for the female predominance of IBS is an alteration 
of CNS processing of visceral information. Studies using PET 
imaging suggest that there are gender differences in regional brain 
responses to rectal pressure in IBS patients; specifically, women 
with IBS show greater activation of brain regions associated with 
affective responses including the amygdala and cingulate cortex 
when compared to men with IBS (Berman et al., 2000; Naliboff 
et al., 2003). Another factor involved in the female predominance of 
IBS relates to the observation that IBS symptomatology fluctuates 
with changes in the female reproductive cycle suggesting a role for 
ovarian hormones in mediating symptom severity (Heitkemper 
et al., 2003). Specifically, IBS symptomatology worsens following 
the peak of estradiol and progesterone in the luteal phase and this 
exacerbation continues into early menses (Crowell et al., 1994; 
Heitkemper et al., 1995). Additionally, concentrations of cortisol, 
epinephrine, and norepinephrine in the urine of female IBS patients 
are significantly elevated throughout the luteal phase compared to 
healthy controls (Heitkemper et al., 1996). There is an extensive 
body of literature supporting multiple interactions between ovarian 
hormones, reproductive states, and the HPA axis which may rep-
resent mechanisms for ovarian hormone-induced increases in IBS 
symptomatology. For instance, female rats typically secrete higher 
basal levels of CORT and show greater ACTH and CORT responses 
to stress. This sex difference is abolished by ovariectomy (OVX) and 
reinstated by estradiol administration (Viau and Meaney, 1991). 
Estrogens may mediate these effects by directly interacting with 
the CRF gene to promote CRF expression and HPA activity in 
addition to interfering with CORT-dependent negative feedback 
leading to increased HPA function both at rest and following a 
stressor (Vamvakopoulos and Chrousos, 1993; Weiser and Handa, 
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2009). In animal studies of GI function, estrous cycle variations in 
visceral pain thresholds have been observed that mirror those seen 
in human subjects. Specifically, proestrus, a phase characterized 
by elevated estradiol and progesterone, is associated with colonic 
hypersensitivity; furthermore, OVX females display decreased 
visceral sensitivity and afferent excitability compared to intact 
females (Ji et al., 2003, 2008; Sapsed-Byrne et al., 1996). Research 
focused on the ability of exogenous estrogens to alter nocicep-
tive and anxiety-like behaviors has led to surprisingly contradic-
tory results; however, there is evidence suggesting that estradiol 
modulates anxiety and fear-related behaviors, visceral sensitivity, 
and somatic pain (Frye and Walf, 2004; Ji et al., 2003; Kayser et al., 
1996; Morgan and Pfaff, 2001). While the effects of progesterone 
are somewhat less clear, there is evidence to support increases in 
indices of anxiety-like behavior and visceral sensitivity as well as 
altered somatic sensitivity following systemic administration (Frye 
and Walf, 2004; Gue, 2000; Gulinello and Smith, 2003). Although 
the specific brain sites mediating the effects of ovarian hormones 
on anxiety and visceral sensitivity are not well defined, a growing 
body of evidence suggests that the amygdala plays a critical role as 
a sexually dimorphic region that expresses receptors for ovarian 
steroids (Frye and Walf, 2004; Greco et al., 2001; Milner et al., 2008; 
Parsons et al., 1982; Rainbow et al., 1982). For instance, a recent 
fMRI study of women in the follicular phase utilized oral admin-
istration of progesterone to mimic hormone levels present during 
the luteal phase and found an increase in CNS activity that was 
highly specific to the amygdala (Van Wingen et al., 2008). Clearly 
more research is required to fully understand the effects of ovar-
ian hormones on IBS symptomatology but the available evidence 
suggests that estradiol and progesterone are important modulators 
of affective and nociceptive behaviors.
neuroendocrIne modulAtIon of the AmygdAlA: 
effectS on AnxIety, vIScerAl SenSItIvIty, And 
SomAtIc pAIn
cortIcoSteroIdS
Similar to other structures in the CNS that modulate HPA activ-
ity, neurons within the amygdala express corticosteroid receptors 
with the highest density found in the CeA (Sapolsky et al., 1983). 
Corticosteroid hormones released from the adrenal cortex act 
through two receptor subtypes, glucocorticoid receptors (GR), and 
mineralocorticoid receptors (MR), which differ in their distribu-
tion and pharmacological properties (De Kloet and Reul, 1987). 
Specifically, effects attributed to MR activation include mainte-
nance of blood pressure and ion balance in target tissues such as 
the kidney, colon, and salivary glands (Marver, 1984), whereas the 
effects of GR activation include regulation of carbohydrate and 
amino acid metabolism and modulation of inflammatory responses 
(Munck and Naray-Fejes-Toth, 1992). Receptor binding studies 
have suggested that CORT acts through MR during basal levels of 
HPA axis activity, whereas GR regulates CORT activity during more 
stressful conditions (De Kloet et al., 1998; Pace and Spencer, 2005). 
Under normal neuroendocrine conditions, the effect of elevated 
CORT in the brain and periphery is largely inhibitory as a compo-
nent of the negative feedback response to stress. Importantly, IBS 
patients display not only elevated plasma CORT (Chang et al., 2009; 
Dinan et al., 2006) but also abnormal amygdala activity (Naliboff 
et al., 2003; Wilder-Smith et al., 2004) and this altered balance in 
stress modulation induced by amygdala hyperactivity may repre-
sent an essential aspect of visceral hypersensitivity. Therefore, it is 
the aberrant amygdala activity in the presence of elevated CORT 
that we consider an important component of IBS symptomatology. 
Our findings that stereotaxic delivery of CORT to the amygdala 
enhances anxiety-like behavior coupled with heightened visceral 
sensitivity and lowered somatic pain thresholds reinforce a direct 
interaction between corticosteroids and the amygdala (Myers and 
Greenwood-Van Meerveld, 2007; Myers et al., 2007). In these stud-
ies the hippocampus and caudate putamen were also targeted with 
CORT micropellets and these placement controls demonstrated 
that the CORT-induced anxiety and viscero-somatic hypersensi-
tivity were specific to the amygdala. Although corticosteroids are 
known to affect inflammatory and immune processes, an additional 
series of experiments confirmed that amygdaloid CORT implants 
and the subsequent increase in peripheral CORT do not affect the 
morphology or immune response of the colonic mucosa. After 
establishing that the effects of CORT implants on anxiety and pain 
sensitivity were specific to the amygdala and did not involve changes 
in the integrity of the colon, we sought to investigate the relative 
contribution of the two types of corticosteroid receptors using 
selective antagonists to GR or MR. Combining the GR antagonist 
mifepristone with CORT revealed a significant reduction in anxi-
ety and colonic sensitivity while spironolactone, an MR antago-
nist, combined with CORT also induced a significant inhibition 
of anxiety and colonic sensitivity. Therefore, at the level of the 
amygdala, both GR and MR play critical roles in the regulation of 
IBS symptomatology.
cortIcotropIn releASIng fActor
Corticotropin releasing factor is a key neuropeptide that has been 
implicated in the neuroendocrine, autonomic, immune and behav-
ioral responses to stress and acts through two main receptor sub-
types, type 1 (CRF1) and type 2 (CRF2) (De Souza et al., 1984). 
Pharmacological studies of CRF action in the CNS and periphery 
have demonstrated the capacity of this neuropeptide to exert major 
effects on enteric function including gastric emptying, colonic 
motility, and mucosal permeability; however, this area will not be 
the focus of this review due to the extensive literature describing 
the effects of CRF on GI function (Tache and Bonaz, 2007; Tache 
and Brunnhuber, 2008; Tache and Perdue, 2004; Tache et al., 1993). 
While endogenous CRF has been shown to play a role in mediating 
stress-induced changes in GI motility and colonic sensitivity, accu-
mulating evidence from animal models suggests that CRF in the 
amygdala may play a role in IBS symptomatology (Gue et al., 1991). 
For example, both emotional stress (contextual fear conditioning) 
and central administration of CRF increase colonic motility and 
these effects are inhibited by direct injection of a cholecystokinin 
(CCK) antagonist into the CeA. Interestingly, the inhibitory effects 
of the CCK antagonist are abolished by lesioning the CeA suggest-
ing that the amygdala is an important site for mediating the effects 
of CRF on enteric function (Gue et al., 1994). Central administra-
tion of CRF also elicits anxiety and fear-related behaviors while 
direct injection of CRF antagonists into the CeA blocks these effects 
(Swiergiel et al., 1993). Furthermore, Wistar–Kyoto rats have been 
shown to have higher levels of anxiety and visceral sensitivity than 
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other rat strains and these findings correlate with increased expres-
sion of CRF in the CeA (Gunter et al., 2000; Shepard and Myers, 
2008). Modulation of the amygdala with CORT also upregulates 
CRF mRNA expression in the CeA and the effects of elevated amy-
gdaloid CORT on anxiety-like behavior and visceral hypersensitivity 
are reversed by antalarmin, a CRF1 receptor antagonist (Myers et al., 
2005; Shepard et al., 2000). Additional evidence for the importance 
of amygdaloid CRF in the regulation of enteric physiology comes 
from a study showing that trinitrobenzenesulfonic acid-induced 
colitis leads to increased CRF mRNA expression in the CeA and 
paraventricular nucleus of the hypothalamus (Greenwood-Van 
Meerveld et al., 2006) demonstrating that acute GI inflammation 
activates the CeA to induce the expression of CRF. The role of amy-
gdaloid CRF in somatic pain processing and pain-related anxiety 
has been well characterized in the kaolin/carrageenan model of 
arthritis. In rats with arthritis-like pain in the knee, a selective CRF1 
receptor antagonist injected directly into the CeA inhibits anxiety 
and nociceptive reflexes induced by mechanical stimulation of the 
knee (Ji et al., 2007). Additional studies focused on the specific 
roles of CRF1 and CRF2 receptors in the amygdala have shown 
that CRF1, by coupling to the PKA intracellular signaling system, is 
pronociceptive while CRF2 is antinociceptive but only active under 
basal conditions (Ji and Neugebauer, 2008). Since CRF is integral 
in mediating the changes that accompany stress and anxiety, this 
peptide may provide a common link in the integration of behavioral 
and visceral responses to stress.
QueStIonS for future reSeArch And the development 
of novel therApeutIc tArgetS
Although our knowledge of amygdala-mediated mechanisms that 
regulate IBS symptomatology has greatly increased, there are sev-
eral outstanding questions that could direct future research toward 
finding effective treatments for functional GI disorders. With the 
knowledge that corticosteroid receptors and CRF in the amygdala 
play prominent roles, determining the specific cellular mechanisms 
regulating their function is essential. Both MR and GR act as tran-
scription factors regulating the expression of many target genes. 
While some of these genes and their protein and enzyme prod-
ucts have been discovered including CRF1, monoamine oxidase 
A, serotonin (5-HT) receptor 1A, and GABA receptor A, there has 
been no systematic analysis of MR and GR responsive genes in 
the amygdala or the role they may play in the regulation of anxi-
ety and visceral hypersensitivity (Morsink et al., 2006). Identifying 
these target genes and the specific isoforms of receptors, enzymes, 
and peptides regulated by corticosteroids could provide promis-
ing therapeutic targets. For example, the interaction of CORT and 
5-HT in the amygdala represents a potentially important aspect of 
anxiety and chronic pain yet has received little attention. Altered 
intestinal 5-HT signaling in IBS has been documented as has the 
ability of CORT to regulate 5-HT receptor expression and binding 
in the hippocampus and extracellular 5-HT concentrations in the 
hypothalamus; conversely, the effects of CORT on 5-HT in the 
amygdala are much less clear (Chalmers et al., 1993; Feng et al., 
2009; Mawe et al., 2006). However, preliminary studies suggest that 
5-HT has CORT-dependent effects on sensory processing in the 
lateral amygdala and that behavioral stress increases extracellular 
5-HT levels in the amygdala (Rueter and Jacobs, 1996; Stutzmann 
et al., 1998). The body of knowledge regarding the intracellular 
signaling of g-protein-coupled CRF receptors is growing with evi-
dence that PKA and ERK are involved in pain-related synaptic plas-
ticity and behavior; however, research is needed to understand the 
regulation of these receptors as well as their downstream signaling 
pathways (Fu et al., 2008). For instance, PKA enzymatic activity can 
be induced by the elevation of cAMP following CRF1 activation; 
however, the targets of PKA catalysis as well as potential transcrip-
tional interactions between PKA and cAMP response elements in 
the amygdala related to pain and anxiety are largely unknown. 
Although ERK is one downstream target of PKA in the regulation 
of neuronal excitability, ERK intracellular signals can activate many 
transcriptional factors and protein kinases in addition to mediat-
ing interactions between the NMDA receptor and brain-derived 
neurotropic factor (BDNF) (Hu and Gereau, 2003; Slack et al., 
2004). There is also a need for long-term studies to address the 
amygdaloid mechanisms involved in the development of chronic 
visceral pain and anxiety. Potential research targets involved in the 
remodeling associated with chronic visceral hypersensitivity would 
include the NMDA receptor and downstream CaMKII which have 
a demonstrated involvement in CRF and stress-related synaptic 
plasticity leading to long-term changes in amygdala activity and 
behavior (Rainnie et al., 2004). Intracellular calcium/calmodulin is 
responsible for the initial activation of CaMKII although the ability 
of the enzyme to autophosphorylate allows for activity to continue 
after the initial rise in intracellular calcium. This sustained activity 
is important for synaptic transmission and plasticity as CaMKII 
is required for long-term potentiation and experience-dependent 
neuronal plasticity (Lisman et al., 2002). The role of amygdala 
hypertrophy is also of special interest in studying the neuroplas-
ticity involved in chronic symptomatology; however, the relative 
importance of amygdaloid neurotropic factors such as BDNF, nerve 
growth factor (NGF), and their tyrosine kinase receptors (TrkB 
and TrkA, respectively) in the regulation of anxiety and visceral 
hypersensitivity has yet to be determined. Neurotropins generally 
promote neuronal survival along with the growth and differentia-
tion of new neurons and synapses. Specifically, BDNF appears to 
be involved in the integration of excitatory and inhibitory neu-
rotransmission and emerging evidence suggests that amygdaloid 
BDNF can regulate anxiety-like behaviors (Pandey et al., 2006; 
Slack et al., 2004). NGF is released in response to inflammation 
and can sensitize primary afferents which may contribute to the 
development of central sensitization. Interestingly, the majority of 
visceral afferents express the NGF receptor TrkA and NGF has been 
shown to regulate pain sensitivity (Di Castro et al., 2006; Hunt and 
Mantyh, 2001). Although the interactions between neurotropins, 
their receptors, and other signaling pathways in the amygdala are 
not well understood, these processes may represent a critical aspect 
of chronic visceral pain and anxiety.
One cautionary note involves the use of animal models to 
address these questions as there are several models of stress-related 
visceral hypersensitivity based largely on the effects of either early-
life trauma or behavioral stressors. The early-life trauma mod-
els involve neonatal rats receiving repetitive challenges such as 
colonic distension, maternal separation, or fear conditioning that 
lead to visceral hypersensitivity in adulthood while behavioral 
models in adult rats utilize physical stressors such as restraint 
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Neuropeptide neuronal efferents from 
stress and psychological stressors including water avoidance stress 
to induce visceral hypersensitivity (Al-Chaer et al., 2000; Gue 
et al., 1997; Rosztocy et al., 2003; Schwetz et al., 2004; Tyler et al., 
2007). However, animal models have important limitations that 
must be considered when interpreting the results of these stud-
ies. First, the nature of the stressors, including whether they are 
physical/psychological, acute/chronic, or predictable/unpredict-
able, can have a profound influence not only on the outcome of 
the investigation but also on the biological processes involved. In 
many animal models stress responses will habituate to the repeated 
presentation of a homotypic stressor; therefore, models that do not 
develop habituation or unpredictable stressors may better mimic 
the human pathophysiological condition. Second, many of the 
stress models used to study visceral pain tend to induce exagger-
ated pain responses or hyperalgesia and, although IBS patients 
also display hyperalgesia, painful responses to innocuous stimuli 
or allodynia is a more common clinical complaint. This issue has 
particular relevance for translational work focused on the devel-
opment of therapeutics as different neurobiological mechanisms 
are involved in allodynia and hyperalgesia. Finally, IBS is a com-
plex, multifactoral disorder involving higher cognitive and cortical 
function as well as complicated interactions between biological, 
psychological, and sociological variables that no animal model will 
be able to mimic entirely. Taking these limitations into account, 
the authors still consider the ascending and descending connec-
tivity of the amygdala to represent important mechanisms for 
better understanding IBS pathophysiology and possibly improving 
therapeutic outcomes for patients.
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